Home Posts Page | TB Online Nachrichte

AstraZeneca Pours €13 Billion into China Market Expansion

East Asia

Tendenzblick

-

February 1, 2026

AstraZeneca Pours €13 Billion into China Market Expansion

On January 29, 2026, as winter still gripped Beijing, AstraZeneca delivered one of the largest foreign investment announcements in China’s pharmaceutical sector in decades. The British drugmaker said it plans to invest more than 100 billion yuan (approximately €13 billion) in China by 2030 to expand its footprint in drug manufacturing and research and development. It is the company’s largest single investment in the country since entering the Chinese market in 1993.

The scale of the commitment sets a new benchmark for multinational pharmaceutical investment in China. More significantly, industry analysts say, it signals a strategic shift: from viewing China primarily as a vast sales market to positioning it as a core node in the company’s global innovation network.

“This is not just a capital injection; it is a declaration that China is being elevated from an ‘important market’ to a ‘global source of innovation,’” commented one analyst who tracks multinational drugmakers in China. The defining feature of AstraZeneca’s latest move, the analyst noted, is its full value-chain coverage, from early drug discovery and clinical development to large-scale manufacturing, deeply embedded within China’s domestic innovation ecosystem.

The timing reflects structural changes in China’s pharmaceutical landscape. In 2025, China’s National Medical Products Administration approved 76 innovative drugs, including 47 chemical medicines, 23 biologics and six traditional Chinese medicines, a record high. The approvals highlight the rapid launch of diversified, cutting-edge therapies in the country. More broadly, China has emerged as a significant source of global biopharma innovation: roughly one-third of global licensing deals now involve Chinese biotech firms, while China accounts for more than 30% of global clinical trials in frontier areas such as cell therapy and antibody-drug conjugates (ADCs).

AstraZeneca’s investment comes with an immediate expansion of partnerships. Shortly after announcing the 100 billion yuan plan, the company unveiled a potential collaboration with CSPC Pharmaceutical Group valued at up to €16.5 billion (about 128.5 billion yuan), including an upfront payment of €1.1 billion. Under the agreement, AstraZeneca will obtain global exclusive rights to a portfolio of once-monthly injectable weight management therapies, including SYH2082, a long-acting GLP-1/GIP receptor agonist that is ready to enter Phase I trials, as well as three preclinical candidates based on different mechanisms. The two sides will also collaborate on additional projects leveraging CSPC’s long-acting drug delivery and AI-powered peptide discovery platforms.

Pascal Soriot, Chief Executive Officer of AstraZeneca, said that China not only has a large patient population in urgent need of the company’s medicines, but also offers an outstanding innovation environment and strong scientific capabilities. He added that by working together and placing innovation at the center of cooperation, many of today’s global challenges can be addressed.

The partnership builds on prior collaborations between AstraZeneca and CSPC, bringing the cumulative transaction value of their agreements over the past two years to more than $25 billion. In 2025 alone, AstraZeneca signed five major deals in China worth over $10 billion, making it one of the most active multinational players in the country’s licensing market.

Behind this flurry of activity lies a broader technological transformation reshaping global pharma. Beyond GLP-1 therapies for metabolic diseases, next-generation modalities—including cell and gene therapies, ADCs and bispecific or multispecific antibodies—are redefining pipelines worldwide. According to data from the NextPharma database, next-generation innovative drugs accounted for 39% of Chinese companies’ R&D pipelines in 2024, up from 27% in 2021. In potential first-in-class products, Chinese firms represent as much as 62%, underscoring their growing role in shaping, rather than following, global drug discovery trends.

AstraZeneca’s 100 billion yuan plan aims to anchor the company within this evolving ecosystem. The investment will strengthen its capabilities in cell therapy and radioconjugate drugs and support a diversified pipeline targeting cancer, hematological disorders and autoimmune diseases. In research, its global strategic R&D centers in Beijing and Shanghai will continue to coordinate with more than 500 clinical hospitals. Over the past three years, these centers have led numerous global clinical trials. On the manufacturing side, AstraZeneca plans to upgrade facilities in Wuxi, Taizhou, Qingdao and Beijing, which already supply medicines to more than 70 markets worldwide. Following its 2024 acquisition of Gracell Biotechnologies, the company is set to become the first multinational biopharma with end-to-end cell therapy capabilities in China.

The company’s China pipeline now includes more than 200 projects—nearly double the number in 2020—and by 2030, AstraZeneca expects around 20 new drugs to be approved. In areas such as gastric and liver cancer, which have high prevalence in China, local R&D teams are leading close to 20 global clinical trials. Regulatory reforms have been pivotal: before 2015, new drugs typically reached the Chinese market five to seven years after approval in the U.S. or Europe. Today, simultaneous submissions in China and the U.S. are increasingly common, and in some cases China has moved ahead.

The investment also reflects a more open policy environment. Revisions to the Foreign Investment Law and Drug Administration Law have aligned treatment of domestic and foreign firms and enabled synchronized global development of innovative drugs. Pilot programs such as the Boao Lecheng International Medical Tourism Pilot Zone in Hainan have accelerated access to urgently needed imported medicines. Officials have reiterated plans to expand market access in services, including healthcare, and to further optimize foreign investment policies.

AstraZeneca’s broader engagement goes beyond capital expenditure. The company expects its China workforce to exceed 20,000 and has launched initiatives such as a global oncology R&D postdoctoral program in China to cultivate scientific leaders. Its Wuxi manufacturing site, which has received more than $860 million in cumulative investment, has adopted over 30 Industry 4.0 technologies and was named a “Lighthouse Factory” by the World Economic Forum, improving production efficiency by 40% while reducing energy consumption by 25%. The model, executives say, is helping raise standards across domestic supply chains.

In parallel, AstraZeneca has expanded public health initiatives aligned with China’s “Healthy China 2030” agenda. Its early cancer screening programs now cover more than 130 cities, and it supports 139 regional diagnosis and treatment centers for rare diseases. In 2025 alone, the company’s innovative medicines benefited 68 million patients in China.

For AstraZeneca, China is already its second-largest market globally and a strategic innovation hub. Since establishing a presence in 1993, the company has introduced more than 40 innovative medicines across oncology, respiratory, cardiovascular, renal, metabolic, gastrointestinal and rare disease areas. Its trajectory—from opening a representative office to building manufacturing capacity in Wuxi in 2001, and later acquiring domestic biotech firms—mirrors China’s broader reform and opening-up process.

The announcement also carries diplomatic overtones. Marking the 53rd anniversary of ambassadorial-level relations between China and the United Kingdom, the investment has been framed by British officials as evidence of continued global engagement. For China, it underscores an ambition to transform from the “world’s factory” into a “global innovation engine.”

Drug development cycles are long and fraught with uncertainty, Soriot acknowledged the risks inherent in pharmaceutical innovation but expressed confidence in the industry’s trajectory. Soriot stated that the medical community is not far from conquering certain forms of cancer, emphasizing that science, innovation, and cross-border cooperation remain essential to addressing global health challenges.

As research labs in Beijing and Shanghai push forward with late-stage projects and manufacturing lines in Wuxi, Taizhou, Qingdao and Beijing ramp up production for domestic and international markets, AstraZeneca’s investment sends a clear signal. For multinational pharmaceutical companies, China is no longer simply a destination for sales growth. It is increasingly a partner in defining the next wave of global medical innovation.

Source: sina finance, eastmoney, zhihu, sohu, 36kr

RMB Poised to Join Top Three Global Currencies Within Five to Ten Years Through Internationalization

Interview

Tendenzblick

-

January 31, 2026

0

RMB Poised to Join Top Three Global Currencies Within Five to Ten Years Through Internationalization

In 2026, following a breakthrough past the key 7.0 mark against the U.S. dollar, the RMB has continued to strengthen. The last time the currency appreciated from 7.3 past 7.0 was in early 2008. What underlies this current wave of RMB appreciation, and how sustainable is it? Since the outbreak of the Russia-Ukraine crisis, the internationalization of the RMB has made remarkable progress.

Looking ahead to China’s 15th Five-Year Plan, how will the country continue to advance its uniquely Chinese approach to RMB internationalization? In the midst of a rapidly expanding digital currency landscape, what opportunities and challenges lie ahead for China as it seeks to build a strong and globally influential financial system?

Professor Zhang Chun of Shanghai Jiao Tong University’s Antai College of Economics and Management shares his insights.

The RMB recently crossed 7 against the U.S. dollar. Is this a short-term move or a long-term trend? How sustainable?

Over the past 20 years, the RMB has generally appreciated. By purchasing power parity, Chinese goods have long been cheaper than U.S. goods, creating upward pressure on the currency. In contrast, high asset prices, especially in real estate, have at times created downward pressure.

Today, with real estate down and exports still competitive, trade goods dominate again, giving the RMB room to strengthen. Long-term, China’s manufacturing edge and ongoing internationalization support appreciation. Short-term swings will depend on asset prices, if stocks or real estate rise sharply, the currency could face temporary depreciation.

In short, the RMB has a long-term upward trend, but short-term fluctuations are inevitable.

If the RMB keeps rising, how will exporters, jobs, and consumers be affected?

In the short term, any RMB appreciation has both benefits and costs, affecting different groups differently.

The main benefit now is increased purchasing power. A stronger RMB lets China and its citizens buy more goods and services, supporting the shift to a consumption-driven economy. It also helps reduce the pressure from China’s historically large trade surplus, easing international tensions.

The main downside is that higher currency value can hurt exporters and reduce related employment. However, long-term, the impact of technology and automation is likely a bigger factor than the exchange rate.

Overall, the advantages of gradually appreciating RMB outweigh the drawbacks. A steady, moderate rise is preferable to a rapid jump, which could harm the real economy.

RMB internationalization has fluctuated over the past decade. What drives these changes?

China first proposed RMB internationalization over 20 years ago, along with opening the capital account for free capital flows. Early on, the focus was efficiency, allowing the RMB to be freely exchanged for foreign currency and used in global payment and investment systems.

But after the U.S. financial crisis, rising geopolitical tensions, and events like the 2015 stock market crash, China slowed the pace to manage risks. Unrestricted capital flows could destabilize the domestic economy, as seen when Russia was cut off from SWIFT in 2022.

In recent years, amid trade tensions, China has revisited internationalization, now pursuing multiple paths, including building an offshore RMB system. The goal is to gradually expand international use while keeping onshore markets stable.

RMB internationalization will be a long process, similar to how the dollar took decades to become the dominant global currency after the U.S. surpassed the U.K. Economists estimate China’s GDP could surpass the U.S. in 10–20 years, but creating a truly “strong” international currency requires decades to build a full system.

China aims to develop six financial systems: monetary policy, market structure, financial institutions, regulation, products and services, and financial infrastructure. Offshore centers, like Hong Kong, Shanghai’s Lingang district, Hainan, and Qianhai, are being used as experimental zones to develop these systems.

Offshore RMB markets can freely attract global capital and offer investment products, which will gradually integrate with onshore markets. Over time, possibly 20 to 30 years, this approach could establish a robust, internationally influential RMB, following a unique Chinese path that balances openness with financial stability.

Will China maintain cautious onshore capital liberalization while using offshore markets to expand the RMB’s financial functions?

In the near term, RMB internationalization is likely to rely on cautious onshore capital controls while developing offshore markets to handle settlement, reserves, pricing, and investment. Full onshore capital account liberalization remains risky due to geopolitical tensions, if China had fully opened a decade ago, crises like the trade war, Russia-Ukraine conflict, and COVID-19 could have triggered massive capital flight.

Economic theory also supports caution. Research on the “trilemma” shows that a country cannot simultaneously maintain monetary independence, exchange rate stability, and fully open capital accounts. China has chosen to prioritize financial stability and sovereignty.

As a result, offshore markets are key. Regions like Hong Kong, Shanghai’s Lingang district, Hainan, and Qianhai are developing freely convertible RMB zones, serving global investors and overseas Chinese companies. Offshore markets are insulated from onshore risks, allowing experimentation with products like “offshore trade bonds” and potentially a RMB-denominated stock market in Hong Kong.

This approach mirrors China’s early special economic zones: test innovations offshore first, then integrate successes into the domestic market. Gradually, these offshore systems will support a broader, internationally influential RMB while keeping onshore risks manageable.

BRICS initiatives like BricsPay and mBridge are aimed at bypassing SWIFT. Are they still conceptual, and what role could the RMB play?

The BRICS group has expanded to 11 members, but differences in politics, economics, and institutions make a unified financial system difficult. While issuing a joint BRICS currency or digital currency is theoretically possible, consensus among diverse members, like China and India, would be very hard to achieve.

A more feasible approach is the mBridge project, a “central bank digital currency bridge” that allows different CBDCs to be exchanged via blockchain. Pilot transactions have already taken place between China, Thailand, and the UAE, coordinated by the BIS Innovation Hub in Hong Kong.

However, mBridge is still a trial. Its long-term scalability and adoption by other countries, especially in Europe, remain uncertain. For now, digital currency bridges are just one of several potential paths for advancing RMB internationalization.

Should digital RMB internationalization also follow cautious onshore liberalization? What are the biggest challenges?

The biggest challenge for digital currency is the existing global financial system. The U.S. dollar system has been established for over a century, and blockchain and AI technologies are now reshaping the foundation of money and payments. The U.S. is adapting through stablecoins, blockchain-backed, dollar-pegged digital currencies used for payments and settlement.

China faces a dual challenge: building a full RMB financial system on blockchain, and ensuring it is fully internationalized. The digital RMB, built directly on blockchain, could allow China to “leapfrog” by creating an offshore system first, then integrating onshore. Unlike many other digital currencies, China’s system is designed to support the real economy, not speculation.

Shanghai’s offshore RMB framework is aimed at serving overseas Chinese companies, enabling them to conduct financing and investment in RMB without relying on foreign currencies. Domestic caution, such as limits on stablecoins or tokenized assets, is deliberate, protecting investors while building a robust, internationally compatible system.

If implemented well, China could establish a high-standard, blockchain-based RMB system, turning challenges into an opportunity to advance currency internationalization.

The 15th Five-Year Plan removed “cautious” from its call to internationalize the RMB. Does this signal acceleration? What are the main bottlenecks?

RMB internationalization is inevitable but will be a long journey. Onshore markets cannot fully open yet, so China is first building offshore financial zones, a proven strategy from past reforms. Recent developments, including growing national strength and global recognition of China’s role, have renewed momentum for internationalization.

Overseas Chinese companies now need more than trade settlement, they require financing in RMB for investment projects abroad. Currently, offshore RMB products for equity, bonds, and derivatives are limited, so many firms still rely on dollars or euros. Expanding these offshore financial tools is key to boosting RMB usage globally.

Looking ahead, in the next five to ten years, China could move the RMB into the top three global currencies for payments and reserves. The U.S. dollar will remain first, and the euro is also strong, but China may surpass the euro in some areas, marking a major step in internationalizing its currency.

With de-dollarization hopes after 2022 not fully materializing, how can the RMB catch up in global payments and reserves, and when might it become a “strong currency”?

Some people predict the RMB could one day replace the U.S. dollar, like the dollar replaced the pound. I think this is overly optimistic. Both the U.S. and China face economic challenges, and China’s onshore financial system is not yet ready for full internationalization. That’s why RMB internationalization is currently focused offshore.

Catching up to the dollar could take 30 to 50 years, and even then, China may not aim to fully replace it. History shows that currency dominance carries costs: the U.S. dollar’s strength contributed to industrial hollowing. Rapidly pushing the RMB into global dominance could similarly harm China’s export competitiveness.

Instead, China is likely to focus on a high-level offshore RMB market. Within five to ten years, the RMB could reach the second tier of global currencies, potentially capturing around 20% of global currency usage—a realistic and beneficial pace that supports the real economy without pursuing currency hegemony.

Source: Guancha, China Daily, Xinhua, CGTN

The Cross-Strait Divide Stems from Taiwan’s Lack of Modern Chinese Historical Experience

POLITIK

Tendenzblick

-

January 29, 2026

0

The Cross-Strait Divide Stems from Taiwan’s Lack of Modern Chinese Historical Experience

When cross-Strait tensions intensify and geopolitical uncertainty deepens in East Asia, questions surrounding Taiwan are once again thrust to the center of strategic debate. Against this backdrop, Wu Zhe, Associate Research Fellow at the Institute of Modern History, Academia Sinica in Taiwan, has offered a sweeping historical and political reflection on the roots of Taiwan’s identity divergence, the unfinished process of decolonization, and the broader trajectory of Chinese national reconstruction. His analysis situates contemporary tensions not merely within present-day political maneuvering, but within a longer historical arc shaped by imperialism, colonial rule, Cold War structures, and competing narratives of modernity.

Wu argues that one of the central reasons the mainland struggles to fully comprehend Taiwan society lies in insufficient familiarity with Taiwan’s experience under Japanese colonial rule from 1895 to 1945. In his view, Taiwan’s social structure at the end of World War II was defined not only by the repression of the Nationalist government after retrocession, but by fifty years of deep colonial transformation that had not yet undergone thorough decolonization.

Japanese rule reshaped education, historical memory, social hierarchy, and identity formation at multiple levels. While there were Taiwanese who preserved Chinese cultural consciousness and resisted colonial domination, Wu emphasizes that they were not the social mainstream under conditions of intensive imperial assimilation. Colonial governance did not rely solely on coercion; it also fostered psychological identification with the empire. The long-term effects of this process continue to reverberate in contemporary Taiwan.

He places particular weight on the divergence of historical experience between Taiwan and the mainland during the crucial decades that forged modern Chinese national consciousness. The 1911 Revolution, the May Fourth Movement, and, most importantly, the War of Resistance Against Japanese Aggression from 1931 to 1945 were formative events in the mainland’s transformation from a dynastic empire to a modern nation-state.

Taiwan, having been ceded to Japan in 1895, did not undergo these same collective awakenings on a societal scale. Although some Taiwanese intellectuals and activists participated in anti-Japanese struggles or maintained cultural and political links to China, the island as a whole did not experience the same broad-based national mobilization. This historical discontinuity, in Wu’s analysis, left Taiwan’s modern national identity development incomplete and structurally distinct.

Wu further contends that the legitimacy and meaning of China’s War of Resistance should be distinguished analytically from the broader framework of World War II. While the global war reflected competing imperial interests and ultimately transitioned into the Cold War, China’s anti-Japanese struggle was part of a longer anti-colonial movement dating back to the mid-nineteenth century.

It was a fundamentally just struggle for national survival and decolonization. Yet the immediate onset of the Cold War after 1945, he argues, interrupted the full realization of China’s anti-colonial project. Taiwan’s retrocession restored Chinese sovereignty in legal terms, but the deeper process of decolonization remained incomplete. Structural compromises made by the Nationalist regime in order to consolidate its rule—both domestically and in alignment with external powers—limited the depth of transformation on the island.

Within this unfinished transition, Wu situates the enduring controversies surrounding the 1947 “February 28 Incident.” He cautions against simplistic categorizations that reduce the event to a single narrative, whether as a purely anti-government uprising, a “people’s revolution,” or an ethnic confrontation.

In his interpretation, multiple currents intersected: residual colonial mentalities hostile to mainland arrivals, revolutionary activism influenced by leftist movements, and the broader instability of a society in the midst of incomplete decolonization. The failure to accurately grasp the principal contradiction of that historical moment, he suggests, contributed to long-term narrative fragmentation. In contemporary Taiwan politics, competing interpretations of 1947 have been instrumentalized to serve divergent ideological projects, particularly the “de-Sinicization” narrative advanced by pro-independence forces.

Central to Wu’s broader thesis is the argument that colonial influence in Taiwan was not limited to political administration but extended deeply into epistemology and historiography. Japanese colonial education systematically restructured historical understanding by fragmenting the continuity of Chinese civilization and undermining the traditional concept of “Great Unity” that historically underpinned Chinese statecraft.

By portraying successive dynasties as unrelated regimes rather than as expressions of a continuous civilizational polity, colonial historiography weakened the intellectual foundation of shared national identity. Wu maintains that contemporary “Taiwan independence” textbooks inherit this framework, emphasizing discontinuity, marginalizing the centrality of the Chinese heartland, and reframing China’s historical territorial evolution as imperial expansion rather than organic state formation.

He also identifies a broader shared predicament across both sides of the Strait: the internalization of Western-centric modernization paradigms transmitted through Japan. In this view, Japan functioned as an intermediary disseminator of Western models of political and economic development, embedding the assumption that legitimacy derives from conformity to Euro-American standards.

This intellectual inheritance shaped not only colonial Taiwan but also segments of mainland intellectual discourse during the late Qing and Republican periods. The result, according to Wu, has been a persistent normative anxiety—a tendency to measure China against externally defined benchmarks and to doubt the civilizational legitimacy of indigenous development paths. He suggests that even today, remnants of this mindset linger, complicating the consolidation of full cultural confidence.

Wu extends his analysis to other frontier regions such as Xinjiang, Tibet, and Inner Mongolia, arguing that historical episodes of separatism or external intervention in these areas demonstrate a consistent pattern: when local interests are aligned from the grassroots level with the broader interests of the Chinese nation, separatist currents lose structural support. In his view, durable national integration requires not merely administrative control but the organic convergence of people’s material and cultural interests with the larger national project. Applying this logic to Taiwan, he argues that decolonization and the reconciliation of underlying social interests must proceed simultaneously. Emotional integration cannot be achieved through rhetoric alone; it requires structural alignment of interests and a sober reckoning with colonial legacies.

Wu rejects bloodline determinism as an explanation for identity divergence. The overwhelming majority of Taiwan residents, he notes, descend from migrants from Fujian and Guangdong. The persistence of pro-independence sentiment cannot be attributed to ethnic difference but must instead be understood through the lens of colonial conditioning and political mobilization. Colonialism operates not only by transplanting populations but by reshaping consciousness. To assume that shared ancestry automatically guarantees political identification is, in his assessment, a misunderstanding of both nationalism and colonial dynamics.

At the same time, Wu identifies grounds for cautious optimism. Traditional cultural values—such as family responsibility and communitarian ethics—remain deeply embedded in Taiwanese society. Cross-Strait exchanges since 1987 have generated nearly four decades of new shared experience, particularly through economic integration within the broader Chinese market. Taiwan’s economic growth in recent decades, he observes, has been inseparable from the rise of the mainland economy. These interdependencies constitute a new historical layer that cannot be easily severed. While political forces may seek to instrumentalize social welfare or identity narratives for electoral gain, the structural reality of intertwined interests endures beneath the surface.

For Wu, the Taiwan question is fundamentally a question of completing an unfinished historical process that began in the nineteenth century: resisting imperial encroachment, restoring civilizational confidence, and consolidating a modern Chinese nation-state grounded in its own values rather than externally imposed paradigms. Decolonization, in this understanding, is not merely the removal of foreign rule but the recovery of historical continuity and intellectual autonomy. Only by confronting the colonial layers embedded in historical memory and educational systems, he contends, can genuine national reconciliation and long-term stability be achieved.

In this broader civilizational perspective, Taiwan is not an isolated anomaly but a critical chapter in the ongoing project of Chinese national rejuvenation. The resolution of cross-Strait differences, in Wu’s framework, ultimately depends on the reintegration of historical narrative, cultural confidence, and material interests into a coherent national whole.

Source: Guancha, xinhua, cgtn, kan china

Chinese Researchers Identify Promising Treatment Pathway and Drug Candidate for Nipah Virus Outbreak in India

Uncategorized

Tendenzblick

-

January 27, 2026

0

Chinese Researchers Identify Promising Treatment Pathway and Drug Candidate for Nipah Virus Outbreak in India

An outbreak of Nipah virus in India’s eastern state of West Bengal has once again pushed one of the world’s deadliest emerging pathogens into the spotlight. Several confirmed cases have been reported, more than 100 people are under quarantine, and neighboring countries including Thailand and Nepal have tightened health screening measures for travelers arriving from India. Though the scale of the outbreak remains limited, the ripple effects have been immediate, underscoring how quickly regional health threats can acquire international significance.

According to the World Health Organization, Nipah virus is a zoonotic pathogen that can be transmitted to humans from infected animals, most commonly fruit bats or pigs, or through food contaminated with their saliva, urine or excreta. In rare cases, human-to-human transmission can also occur. The clinical picture is alarming: infection can lead to acute respiratory illness and fatal encephalitis. There is currently no licensed vaccine and no specific antiviral therapy approved for Nipah virus infection. Mortality rates vary between 40% and 75%, depending on local surveillance capacity and clinical care, and the incubation period can stretch up to 45 days, complicating containment efforts.

Against this sobering backdrop, new research from China has drawn attention. Scientists from the Wuhan Institute of Virology, working with partners including the Shanghai Institute of Materia Medica and biotechnology firm Vigonvita, reported in the journal Emerging Microbes & Infections that the oral nucleoside drug VV116 demonstrates significant antiviral activity against Nipah virus in preclinical studies. VV116, a broad-spectrum antiviral candidate co-developed by Vigonvita and Junshi Biosciences, is designed to target viral RNA-dependent RNA polymerase (RdRp), a key enzyme required for viral replication.

Laboratory experiments showed that both VV116 and its active metabolite inhibited replication of different Nipah strains, including the Malaysia (NiV-M) and Bangladesh (NiV-B) variants. In a lethal-dose hamster model, oral administration of 400 mg/kg improved survival to 66.7% and significantly reduced viral loads in target organs such as the lungs, spleen and brain. Researchers described the findings as the first evidence supporting VV116’s therapeutic potential against Nipah virus, suggesting it could one day serve not only as a treatment but also as a prophylactic option for high-risk groups such as healthcare and laboratory workers.

Still, caution tempers optimism. Industry experts note that the current data remain preclinical; extensive clinical trials would be required before any real-world use. That path is costly, time-consuming and fraught with uncertainty, particularly for a sporadic but high-fatality virus like Nipah. The pathogen first emerged in 1998 in Malaysia, where 265 cases of acute encephalitis were recorded between 1998 and 1999, resulting in 105 deaths and heavy economic losses. Since then, periodic outbreaks in South and Southeast Asia have kept global health authorities on alert.

VV116 itself has had a complex commercial trajectory. Originally developed for COVID-19, it received approval in China and in Uzbekistan as Mindvy® for treatment of SARS-CoV-2 infection. In 2023, milestone payments and royalties from a cooperation agreement with Junshi Pharma drove Vigonvita’s annual revenue above 200 million RMB, with VV116 accounting for the overwhelming majority. Yet as COVID-19 receded and antiviral demand cooled, sales momentum waned. The drug secured broader approval in China in early 2025, but its market outlook appeared diminished compared with the pandemic peak.

Seeking to revive its commercial and clinical prospects, the company has pivoted toward other RNA viruses. A Phase II clinical trial of VV116 for respiratory syncytial virus (RSV) infection was completed in China in September 2025, and in December the firm granted Simcere Pharmaceutical exclusive rights in Greater China to develop, manufacture and commercialize VV116 for RSV and human metapneumovirus (HMPV). Company disclosures have also highlighted inhibitory activity against Zika virus and Nipah virus, positioning VV116 as a potential multi-indication antiviral platform rather than a single-disease product.

Parallel to therapeutic research, diagnostic preparedness has intensified. China’s newly revised Frontier Health and Quarantine Law, implemented in 2025, includes Nipah virus in its list of notifiable pathogens subject to inspection. Although no human or animal infections have been reported domestically, authorities have advised vigilance without panic, urging the public to follow official guidance and avoid unnecessary travel to affected areas such as West Bengal.

Rapid and accurate laboratory diagnosis remains central to outbreak control. In recent days, several Chinese in vitro diagnostics companies have announced Nipah-related testing capabilities. Liferiver emphasized early nucleic acid detection to compensate for the virus’s non-specific early symptoms. Hybribio reported development of a fluorescence PCR-based test kit suitable for port quarantine and disease surveillance. Daan Gene has similarly launched a Nipah nucleic acid test. Meanwhile, Wondfo Biotech introduced multiple product formats, including molecular point-of-care testing compatible with its proprietary platforms, and Autobio Diagnostics offers automated extraction and real-time PCR systems designed to deliver streamlined “sample in, result out” workflows.

Together, these developments reflect a broader shift in China’s life sciences sector. Once largely focused on the domestic market, Chinese pharmaceutical and diagnostics firms are increasingly positioning themselves as contributors to global health security. By investing in broad-spectrum antivirals, scalable PCR platforms and rapid-response manufacturing capacity, they are building toolkits that can be mobilized not only for national needs but also for international outbreaks. In an era when pathogens cross borders with ease, such capacity has global implications.

Nipah virus remains a formidable threat, highly lethal, zoonotic, and capable of silent spread during its long incubation period. Whether VV116 or other candidates will ultimately prove effective in humans is an open question. Yet the convergence of drug repurposing, translational research and diagnostic innovation offers a glimpse of how the next generation of outbreak response may look: faster, more coordinated and more international. In that effort, the expanding role of Chinese companies, both in therapeutics and in diagnostics, illustrates how scientific collaboration and industrial readiness can become shared assets in the worldwide fight for public health.

Source: yicai, yahoo, the paper, hkej, sina, hua shang news

Chinese Companies Harness AI to Improve Lives: Ant Group Enables 300,000 Doctors to Serve 91 Million People Online

Uncategorized

Tendenzblick

-

January 25, 2026

0

Chinese Companies Harness AI to Improve Lives: Ant Group Enables 300,000 Doctors to Serve 91 Million People Online

On January 24, 2026, at the GBA Healthcare Association Annual Conference (GBAHA), Hao Df Online unveiled its “2025 Annual Good Doctor Rankings,” recognizing 737 doctors nationwide for their professional expertise and quality service. The release of the list carries added significance, coinciding with the one-year anniversary of Ant Health’s acquisition of the platform.

Founded in 2006 by Beijing Xinyi Qiangguo Technology, Hao Df Online is a pioneering internet healthcare platform in China. Its services include online consultations, remote outpatient visits, post-treatment management, family doctor subscription services, and disease knowledge dissemination. Accessible via its app, website, WeChat official account, and mini-programs, the platform also features the country’s first patient experience sharing system, allowing users to rate doctors and share their medical experiences.

In April 2016, Hao Df established the Yinchuan Smart Internet Hospital in Ningxia, initiating remote expert consultations and family doctor services to support hierarchical medical system development. In October 2022, founder Wang Hang represented the platform in showcasing “Internet Healthcare” achievements for the national “Eastern Data, Western Computing” initiative. In January 2025, Ant Group completed its acquisition of Hao Df Online, announcing plans to jointly develop AI medical assistant services. Hao Df Online subsequently became part of Ant Group’s Alipay Digital Healthcare division. By December 2025, the platform had over 280,000 registered doctors and had served more than 91 million patients. By January 2026, after integration with Alipay and Ant Yikang apps, the registered doctor base had expanded to 300,000.

Zhang Junjie, Vice President of Ant Group and Head of Healthcare Business, revealed at the conference that the integration has accelerated synergies: doctors now reach more patients nationwide, and users can easily access consultations through both Alipay and Ant Yikang apps.

Hao Df Online is also upgrading its doctor workstations with new AI-powered tools such as DeepSearch, creating personalized “AI assistants” to help doctors reduce workload, enhance efficiency, and improve the patient experience. The platform plans to explore innovative practice models with doctors, further amplifying professional expertise.

The expansion of service access points has been particularly transformative. Ant Group has heavily invested in healthcare AI models in recent years, launching the Ant Yikang app in 2025 to serve as an AI health assistant for all users. With over 30 million monthly active users and 10 million daily consultations, the app now links seamlessly with Hao Df Online, allowing users to be matched with qualified doctors across the country. For physicians, this means their influence extends far beyond their local hospitals, reaching patients nationwide.

Doctors have welcomed the change. One physician, active on Hao Df Online for ten years, noted that the platform removes geographic limitations, allowing them to serve patients from neighboring provinces to the entire country. AI handles repetitive tasks such as medical history collection, freeing up more time for direct patient care.

In addition, Hao Df Online’s health education content now integrates fully with Alipay, enabling doctors to conduct live broadcasts and share videos that reach millions of users. In the past year alone, doctors produced over 15,000 live sessions and more than 100,000 articles and videos. This represents a shift from treating illnesses to promoting preventive health, highlighting the growing importance of health education in medical value.

AI adoption is also increasing among doctors. More than 1,000 physicians, led by six academicians, have launched their own AI “avatars” on the Ant Yikang app, answering over 27 million user health queries to date. Digital technology is fundamentally reshaping healthcare delivery and efficiency.

Academician Zhong Nanshan, speaking at the conference, emphasized that smart healthcare is meant not to replace doctors, but to enable them to focus on patient-centered care, addressing the persistent issues of expensive and difficult access to medical services in China.

AI assistants aim to tackle efficiency challenges directly. Liu Junwei, general manager of Ant Group’s Medical and Health Business Unit and head of AI Health Manager, outlined upgrades coming to the Hao Df doctor workstation in 2026. Enhancements include deepening “human-machine collaboration,” allowing doctors to create AI avatars for answering routine queries and providing health education. Each doctor will also have a personal AI assistant to collect medical histories, assist during consultations by providing real-time diagnostic suggestions, and generate post-visit summaries and personalized follow-up plans. Additionally, the new DeepSearch feature will support literature review and clinical research, creating a Chinese version of Open Evidence freely available to physicians.

At the conference, Hao Df Online released its 2025 Annual Good Doctor Rankings, marking the 13th consecutive year of the list. The rankings, which assess service volume, depth, responsiveness, patient satisfaction, and offline reputation, recognized 737 top doctors from a pool of over 300,000. This year, 668 were named “Annual Good Doctors,” 15 as “Young Good Doctors,” 48 as “Long-term Online Doctors,” and 30 received the newly introduced “Health Education Doctor” award.

Founder Wang Hang highlighted that 2026 marks both the second year of Hao Df’s integration into the Ant ecosystem and the 20th anniversary of its founding. He said the combination of Ant Group’s platform resources and AI capabilities has unlocked new professional value, helping Hao Df confidently enter the AI era. The platform plans to continue innovating practice models, expanding the professional impact of doctors, and delivering health services to more people.

The evolution of internet healthcare in China is shifting from monetizing traffic to realizing professional value. AI tools now enable doctors to extend their service reach, improve clinical efficiency, and accelerate research support, effectively amplifying the impact of medical expertise nationwide.

Source: guancha, sina, jinguxun, ant group, eeo

Collective Genius Behind China’s EV Boom: BYD Employs 120,000 Engineers Focused on R&D

Uncategorized

Tendenzblick

-

January 23, 2026

0

Collective Genius Behind China’s EV Boom: BYD Employs 120,000 Engineers Focused on R&D

“BYD is like a simple, hardworking kid—honest, diligent, and focused on learning,” Wang Chuanfu, chairman and founder of BYD, told investors in December 2025 during the company’s shareholder meeting, once again framing his company through the lens of a practical engineer.

Over the past decade, BYD’s new energy vehicle sales have soared from 58,000 units to 4.6 million in 2025, a growth fueled not by conventional corporate structures or ready-made supply chains, but by a vertically integrated system of self-generated, highly internalized capabilities.

At the heart of this rise is BYD’s engineering workforce. By 2025, the company employed 120,000 R&D engineers, more than most traditional automakers combined, forming what Wang calls a “technical moat.” New graduates are recruited in large numbers and trained under a rigorous mentorship system, transforming students into engineers capable of tackling complex projects. “Managing this scale of employees requires the precision of managing a single individual,” says Ye Zi, general manager of BYD Human Resources.

Wang’s hands-on involvement shapes the company’s culture and technical decisions. Sun Huajun, CTO of BYD’s battery division, recalls Wang in the early years meticulously dismantling faulty batteries with engineers, searching for millimeter-level sealing flaws. Even today, Wang gives in-depth lessons to senior executives on principles ranging from anodic oxidation to grid capacitors, ensuring that technical understanding permeates every level of leadership. Weekly meetings between Wang and division heads review progress, and major strategic choices, like the company’s commitment to lithium iron phosphate batteries or the innovation of the blade battery, emerge from these intensive discussions, blending technical democracy with authoritative decision-making.

This engineer-driven ethos has powered BYD’s meteoric success. From its origins as a battery manufacturer to its leadership in electric vehicles, BYD has redefined cost and efficiency with proprietary technologies like blade batteries and DM-i hybrid systems, building an industrial empire spanning batteries, semiconductors, and energy storage, all rooted in internal technical mastery. Yet by 2025, the rapid electrification was giving way to the slower, more strategic battle over intelligent technologies, where success would hinge not just on battery efficiency or casting methods, but on software, algorithms, data ecosystems, and speed of iteration.

Wang’s philosophy is deeply embedded in the company’s talent development. Early recruits in the 2000s, often high-ranking graduates from China’s top universities, joined BYD because there were few alternatives.

BYD’s “Tomorrow Star” graduate training program, established at the company’s founding in 1998, combines rigorous corporate culture lessons, immersive production-line training, and one-on-one mentorship. Graduates are quickly placed on real projects, often leading initiatives within their first two years. “BYD dares to let fresh graduates take responsibility,” Ye Zi notes. “Some of them become project leaders within a year or two.” This mentorship-project hybrid system ensures the transmission of both knowledge and company values, creating a continuous pipeline of capable engineers.

The company’s internal operating principles, codified in the internal handbook BYD Basic Guidelines, emphasize that decision-makers cannot succeed by sitting in offices alone; they must engage on the front lines, in labs, production floors, and even sales outlets. Wang exemplifies this approach, personally interacting with engineers to finalize technical strategies, while the 120,000-strong R&D workforce translates vision into reality. The blade battery, for example, emerged from Wang’s insistence on achieving 600 km of range with lithium iron phosphate cells, eventually realized by engineering innovations in production tooling and cell arrangement.

Over time, BYD has cultivated a leadership culture distinct from new electric vehicle startups, favoring internal promotion over poaching talent. More than half of the current general managers reporting directly to Wang are alumni of BYD’s own graduate programs. The company has consistently produced top leaders, including heads of research institutes and brand divisions, all forged under Wang’s mentorship. Management scholars like Jim Collins have long noted that visionary companies succeed when leaders are internally developed, a principle BYD has exemplified.

BYD’s explosive growth over the past decade has reshaped its presence in the talent market. The company now recruits thousands of new graduates annually, many from elite universities, most of whom enter R&D roles. Parallel promotion tracks allow technical experts to reach executive-level pay and status without leaving their craft, ensuring talent retention and career clarity. With a structured nine-tier ranking system spanning multiple sub-levels, engineers can navigate a clear, merit-based career path.

As BYD scaled, its culture of mentorship began to evolve. In 2017, the company introduced a culture of internal competition, later formalized in 2022 as “competing, learning, racing, collaborating, and victory-driven,” emphasizing meritocracy and adaptability. Internal debate is encouraged, but always aimed at outperforming competitors externally. Incentives extend beyond salary, with profit-sharing and equity programs fostering long-term alignment. The system now forms a self-reinforcing loop of selection, development, evaluation, and reward, ensuring that engineers remain aligned with company strategy.

Yet as the industry enters the intelligent mobility era, BYD faces new tensions. Vertical integration, once a source of cost advantage, brings management burdens and potential innovation inertia. Wang has elevated intelligent technologies to a core strategic focus, aggressively recruiting software, algorithms, and human-machine interface talent. By mid-2025, the intelligent driving team exceeded 5,000, including over 1,000 core algorithm engineers. The cultural challenge is integrating highly specialized, digitally native talent into BYD’s disciplined, production-centric engineering culture.

Early signs of synergy are emerging. AI platforms in battery research, for example, enable rapid formulation testing, complementing BYD’s traditional trial-and-error, first-principles approach. Yet the challenge remains: in a large, efficiency-driven organization where internal performance is rigorously assessed, how much room exists for uncertainty and experimentation? In the intelligent era, engineers must not only optimize technology but also understand and create user value.

BYD’s culture of simplicity, “focus on the work, not the person”, remains its guiding principle. It allows the company to command nearly a million employees and a vast industrial chain with the efficiency of a single operator.

Source: BYD, xueqiu, 21jingji, qykc, 36kr, CSDN, xinhua, world journal

Both Colonized by the United States: Why Hawaii Became a State While the Philippines Went Independent

POLITIK

Tendenzblick

-

January 21, 2026

0

Both Colonized by the United States: Why Hawaii Became a State While the Philippines Went Independent

As a late-rising colonial power, the United States acquired relatively few large overseas colonies compared with the European empires. Among them, the Philippines was the most substantial, while Hawaii and Cuba were also significant additions at the turn of the 20th century.

In 1898, amid the Spanish-American War, Washington seized the Philippines from Spain and, in the same year, formally annexed Hawaii. Though separated by thousands of miles of ocean, the two archipelagos, whose Indigenous peoples share Austronesian linguistic roots, fell under American control at nearly the same moment.

Half a century later, however, they chose sharply different paths. In 1946, the Philippines became an independent republic. In 1959, Hawaii voted in a plebiscite to join the United States as its 50th state. Today, their economic fortunes diverge dramatically: in 2024, the Philippines’ per-capita GDP stood at roughly $4,000, while Hawaii’s reached about $60,000, ranking among the higher-income U.S. states. Why did one break away while the other entered the Union? The answer lies in geography, demography, war, and the shifting logic of American power.

At first glance, the Philippines and Hawaii appear distant cousins in both culture and circumstance. Both are island chains whose Indigenous populations belong to the Austronesian family. Yet their scale and strategic positions differ profoundly. The Philippines spans roughly 300,000 square kilometers in Southeast Asia, wedged between Taiwan to the north and Borneo to the south, and historically hosted organized polities such as the Kingdom of Tondo and the Sultanate of Sulu before falling to Spanish rule in the 16th century. Hawaii, by contrast, covers about 16,000 square kilometers in the middle of the North Pacific. Isolated for centuries, it unified under King Kamehameha I in the late 18th and early 19th centuries, forming the Kingdom of Hawaii only decades after Western contact.

By the time American expansionism turned decisively toward the Pacific, both archipelagos were vulnerable in different ways. American missionaries and traders arrived in Hawaii in the early 19th century, drawn by sandalwood and later by sugar. Western firearms helped consolidate Kamehameha’s rule, but Western diseases devastated the Native Hawaiian population, which fell from several hundred thousand to fewer than 50,000 within decades. American planters and businessmen gained growing influence, importing large numbers of Chinese and Japanese laborers to work the sugar plantations. By the late 19th century, Native Hawaiians had become a demographic minority in their own land.

In 1887, under armed pressure from American residents, the Hawaiian monarchy accepted the so-called Bayonet Constitution, stripping the king of much of his authority and empowering foreign property holders. In 1893, a group of American settlers, backed by U.S. Marines, overthrew Queen Liliʻuokalani. Five years later, Congress passed the Newlands Resolution annexing Hawaii, cementing its role as a strategic outpost—especially at Pearl Harbor—as the United States projected power across the Pacific.

The Philippines entered the American orbit through war with Spain. After more than three centuries of Spanish colonial rule, Filipino revolutionaries led by figures such as José Rizal and Andrés Bonifacio had already ignited an independence movement. Emilio Aguinaldo declared independence in June 1898, but the U.S., having defeated Spain, refused to recognize the fledgling republic. The Philippine-American War erupted in 1899 and dragged on until 1902, with sporadic resistance continuing for years. The conflict was brutal and costly, revealing the difficulty of subduing an archipelago of 7.6 million people at a time when the United States itself had a population of only about 76 million.

Demography proved decisive. Unlike Hawaii, the Philippines could not be easily transformed by immigration or demographic dilution. Its population was large, regionally diverse, and culturally complex, shaped by centuries of contact with Asia and Europe. American racial attitudes at the time also complicated the prospect of incorporation; granting citizenship to millions of non-white Filipinos was politically contentious. Governing the territory required sustained military and administrative effort, and external powers, including Japan, loomed nearby.

By contrast, Hawaii’s smaller population and geographic isolation made it easier to secure and integrate. Its strategic value as a naval hub grew during World War II. The attack on Pearl Harbor in 1941 underscored its military centrality, yet U.S. forces retained control. The Philippines, on the other hand, fell to Japanese forces shortly after the war began. Although the U.S. eventually returned, wartime experience reinforced the view in Washington that holding a distant, populous Asian colony against regional powers would be costly and precarious.

Even before the war, Congress had set the Philippines on a path toward self-government through the Jones Act of 1916 and the Tydings-McDuffie Act of 1934, promising eventual independence. In 1946, amid a global wave of decolonization and with the United States positioning itself as a champion of freedom, the Philippines formally became independent.

Yet independence did not sever ties. Manila signed agreements preserving close economic and military links with Washington. Trade legislation granted preferential access to American goods, while U.S. companies retained significant privileges. American military bases remained on Philippine soil for decades, anchoring U.S. strategy in the Western Pacific. During the Korean and Vietnam wars, U.S. spending stimulated segments of the Philippine economy, but structural weaknesses—limited industrialization, elite dominance, and dependence on external demand—persisted. Over time, economic disparities widened, and large numbers of Filipinos sought work abroad.

Hawaii’s trajectory was different. After annexation, it developed around sugar, the military, and, by the mid-20th century, tourism. By the time of the 1959 statehood vote, the islands’ population consisted largely of American settlers and their descendants, alongside Japanese, Filipino, and other immigrant communities. Native Hawaiians, who had once been the overwhelming majority, comprised a minority. Statehood promised full political representation and federal benefits, and it passed with broad support among voters. In subsequent decades, Hawaii’s economy expanded, and its per-capita income rose well above the U.S. average.

The divergent outcomes reflect more than ideology. Geography made Hawaii easier to defend and incorporate, while the Philippines’ size and proximity to Asian powers made permanent annexation impractical. Demography limited the feasibility of demographic transformation in the Philippines, while disease, migration, and intermarriage had already reshaped Hawaii. International politics after World War II also favored formal decolonization, even as new forms of economic and military influence persisted.

Today, the legacies of American rule remain visible in both places. English is widely spoken in the Philippines, and the country maintains close security ties with Washington. In Hawaii, debates over sovereignty, land rights, and historical injustice continue, even as the state enjoys relative prosperity. One archipelago became a sovereign nation navigating the complexities of post-colonial development; the other became a U.S. state embedded within the federal system. Their shared Austronesian roots did not dictate a common destiny. Instead, the interplay of power, population, and global strategy set them on different courses—paths whose consequences are still unfolding.

Source: goHawaii, national geographic, history state gov, matiere volution, US berkeley research

At the Edge of the Himalayas: The Rise of China’s Mainling Airport as a Strategic Air Hub on the Sino-Indian Border

East Asia

Tendenzblick

-

January 19, 2026

0

At the Edge of the Himalayas: The Rise of China’s Mainling Airport as a Strategic Air Hub on the Sino-Indian Border

China is moving to further expand and upgrade Nyingchi Mainling Airport in southeastern Tibet, underscoring the facility’s growing role in both regional development and strategic planning along the country’s southwestern frontier.

On January 10, China’s National Public Resources Trading Platform announced a tender for the preliminary and construction design of a project to enhance the airport’s emergency support capacity, including the expansion of its T2 terminal. The new plans follow a series of infrastructure upgrades in recent years that have steadily increased the airport’s operational capabilities.

Located in the Yarlung Tsangpo River valley in Mainling, Nyingchi, the airport sits at an elevation of 2,948.9 meters above sea level. It lies approximately 19 kilometers southwest of Mainling’s county seat and 50 kilometers north of downtown Nyingchi. Classified as a 4D-level dual-use (civil-military) regional airport, it is considered a “high plateau” airport due to its altitude and complex terrain.

The idea of building a civilian airport in Nyingchi was formally proposed in April 2001, when the Tibet Autonomous Region government submitted plans to the State Council and the Central Military Commission. Construction began in October 2004, and the airport opened to commercial traffic in September 2006. In 2019, work started on a parallel taxiway project, which entered service in March 2021. That expansion included a new parallel taxiway north of the existing runway, two end-connecting taxiways, one vertical connector, additional apron space with six new Code C aircraft stands to the west and two general aviation stands to the east, as well as new support and auxiliary facilities. Military facilities in the vicinity have also undergone upgrades, and a new surface-to-air missile site has reportedly been built to the east.

The airport’s evolution has drawn international attention. The Washington-based Center for Strategic and International Studies (CSIS), through its tracking China’s western airpower expansion project, analyzed developments at Mainling in 2021. In 2023, Indian satellite imagery analyst Damien Simon reported the presence of a WZ-7 high-altitude long-endurance drone parked at the airport, highlighting its growing military relevance near the China-India border.

Beyond its strategic location, Mainling is widely regarded as one of the most challenging airports in the world for pilots. Tibet was once considered by the international civil aviation community to be an “airspace forbidden zone,” known for extreme flying conditions marked by sandstorms, hail, thunderstorms, high-altitude winds and severe turbulence. Among the region’s airports, Nyingchi stands out for its particularly complex meteorological and geographic conditions.

Although its elevation is lower than many other Tibetan airports—ranking 12th in altitude among China’s civil airports—the operational difficulty is often described as the highest in the country and among the most demanding globally. During World War II, the area lay along the infamous “Hump” air route used by Allied forces to supply China over the Himalayas; dozens of transport aircraft were lost in the surrounding mountains.

The airport sits in a narrow river valley frequently covered by low clouds and dense fog, with highly variable wind directions and frequent wind shear. These conditions significantly affect visibility and flight safety. Wind instability is especially dangerous during takeoff and landing, when sudden shifts can cause aircraft to deviate from their flight paths. Pilots must make rapid and precise judgments; errors can have catastrophic consequences.

Wind speeds typically intensify between 2 p.m. and 6 p.m., often exceeding safe limits for aircraft operations. As a result, most flights are scheduled in the morning. According to meteorological data, the airport’s cumulative annual flyable days total only about 100. The distinctive plateau terrain and harsh weather make it China’s most technically demanding airport for flight operations.

To ensure safety within the narrow valley corridors, navigation beacons have been installed at every turning point along flight routes. Wind profile radar systems monitor surrounding wind speed and direction. Because flight paths pass through tight, winding gorges that exceed normal operational standards, aircraft ground proximity warning systems may be triggered during descent. Complex terrain also interferes with navigation signals, limiting available airspace. Notably, the Milin navigation station lies just 11.2 kilometers from the Line of Actual Control between China and India.

Flight crews operating at Mainling must demonstrate exceptional technical proficiency and psychological resilience. Captains are typically veteran pilots with more than a decade of flying experience. The region is also among China’s most lightning-prone areas, with an annual average of more than 47 thunderstorm days. The airport’s exposed valley location, surrounded by open terrain without tall structures, increases the risk of lightning strikes, necessitating comprehensive lightning protection systems across all facilities.

Despite these challenges, the Tibet Airport Group has worked to optimize airspace coordination and strengthen ground service capacity. By assisting airlines in securing overnight slots at out-of-region airports and allocating aircraft to remain overnight, the group has effectively increased route density. During the winter flight season, weekly flight slots reached 262, a year-on-year increase of 26.6%, marking a historic high and providing logistical support for the hydropower project in the lower reaches of the Yarlung Zangbo River, a major regional engineering initiative.

In December 2025, China Civil Aviation Network reported that the Tibet Airport Group had built an aviation express network centered on Nyingchi to serve the Yaxia Project. Key trunk routes linking Nyingchi with Beijing, Chengdu, Chongqing, Guangzhou and Shenzhen have been prioritized. Airlines such as Lucky Air and China Eastern have coordinated capacity adjustments and revenue assessments to launch connecting routes, including services such as Wuhan–Mianyang–Nyingchi. In April 2025, Sichuan Airlines opened a Nyingchi–Chongqing–Hangzhou route, while during July and August, flights between Nyingchi and Chengdu’s Shuangliu and Tianfu airports were increased to nine or ten per day. After the winter schedule change, additional routes linking Nyingchi with Beijing Daxing, Wuhan via Xichang, and Xi’an via Xichang are planned.

To meet the transfer needs of project personnel, airport authorities have focused on improving connection efficiency, reducing minimum transfer times to under 70 minutes. Between January and November 2025, four major hubs—Chengdu, Chongqing, Xi’an and Tianfu—accounted for 315,200 transfer passengers, representing 35.5% of Mainling’s total throughput.

The airport has become a critical logistics node. For travelers, it reduces the physical strain associated with long overland journeys at high altitude. For high-value cargo, air transport overcomes the constraints posed by mountainous terrain. Personnel and materials arriving via the airport highway are dispatched from Nyingchi to dispersed project sites, lowering the logistical threshold for entering the Qinghai-Tibet Plateau.

As infrastructure expands, Mainling Airport is emerging not only as a driver of development for Nyingchi and nearby Medog County, but also as a strategic aviation hub along China’s eastern sector of the border with India. Continued upgrades to its emergency support capacity are expected to further strengthen its role in regional growth and frontier security in the years ahead.

Source: linzhi gov, carnoc, sina, xinhua, ufsoo

Ancient Remedies to Save Modern Lives: The Folk Medicine Collection Movement in Early Communist China

KULTUR

Tendenzblick

-

January 17, 2026

0

Ancient Remedies to Save Modern Lives: The Folk Medicine Collection Movement in Early Communist China

At the founding of the People’s Republic of China, the nation faced an urgent need to develop its healthcare system. Medical resources were scarce, doctors were few, and medicines were limited.

In this context, the Chinese Communist Party recognized the immense value of traditional Chinese medicine and sought to harness its power to save lives. The ancient remedies, secret formulas, and herbal prescriptions preserved among local communities were not merely cultural artifacts. They were vital tools for preventing and treating illnesses and safeguarding the health of millions.

In 1954, the central government explicitly highlighted that traditional Chinese medicine had played a critical role in the survival and development of the Chinese people for thousands of years, and it was essential to actively explore, preserve, and enhance this medical heritage.

In the years that followed, local party committees mobilized communities to collect these folk remedies. What began as a modest effort to gather useful medical knowledge gradually transformed into a nationwide movement. Collecting these remedies was not only a matter of preserving a medical tradition and protecting public health; it was also a step in the broader project of modernizing the nation.

Yet, while recent scholarship has often focused on the contributions of individual doctors, little research has examined the political and social framework of this initiative, or how the government organized and promoted it across the country. Understanding these dynamics provides insight into the intersection of healthcare, politics, and nation-building in early PRC history.

The collection of folk remedies was deeply intertwined with the principles guiding China’s early healthcare policy. The nation faced severe public health challenges: infectious diseases, parasitic infections, and endemic illnesses such as plague, tuberculosis, schistosomiasis, and goiter threatened millions of lives.

Meanwhile, the country’s medical infrastructure was weak, and the domestic production of chemical medicines was insufficient. To address these issues, the government established four guiding principles for healthcare: prioritize workers, peasants, and soldiers; focus on prevention; unite Chinese and Western medicine; and combine healthcare work with mass mobilization. These principles laid the foundation for a healthcare system that could leverage both scientific and traditional knowledge while engaging the population in active public health efforts.

Despite these policies, the principle of uniting Chinese and Western medicine initially received little attention. It was not until Chairman Mao, in June 1954, emphasized the importance of strengthening traditional medicine that the health authorities began to take it seriously. By July, the Ministry of Health issued its first official report on developing Chinese medicine, outlining a systematic plan to collect, verify, and study folk prescriptions.

The government aimed to preserve these formulas, assess their effectiveness, and integrate them into broader medical practice. Shortly thereafter, state newspapers encouraged Western-trained doctors to study traditional medicine, reinforcing the political and scientific importance of the initiative. With these directives, folk remedy collection became a matter of national significance, driven by top-down organization and leadership.

To support this effort, the government established specialized research institutions. Mao instructed the immediate creation of Chinese medicine research centers to recruit skilled practitioners and preserve their knowledge. By late 1955, the Ministry of Health had founded the National Institute of Chinese Medicine in Beijing.

Beyond the national level, provincial and local institutions were established to expand the reach of this work, creating a network of research centers, hospitals, and universities dedicated to collecting and studying traditional remedies. By the early 1960s, almost every province had its own research institute, forming the backbone of a nationwide effort to safeguard China’s medical heritage.

The initial phase of remedy collection was deliberate and structured. In 1954, regional and provincial meetings of traditional medicine representatives began sharing clinical experiences and testing effective remedies. Gansu Province collected over 800 prescriptions in a single year, while Fujian, Hebei, Henan, and Yunnan provinces compiled thousands more. These early efforts were largely limited to licensed practitioners and scholars, but they established models and methodologies that would later support mass participation.

By 1958, the campaign entered a new stage, evolving into a nationwide movement with mass involvement. National conferences on medical technology and Chinese medicine advocated public participation in collecting and documenting folk remedies.

Hebei Province set an early example, organizing a “people’s collection” campaign with the slogan: “Everyone contributes, everyone discovers, unearths everything from the people.” Within weeks, over 160,000 remedies were gathered, inspiring other regions to follow suit. State media amplified this call to action, framing the initiative as a patriotic duty and a practical contribution to public health.

Communities across China embraced the movement. In Shaanxi, local authorities organized public gatherings to encourage citizens to share remedies, while Henan collected over a million prescriptions in a single year. Hebei produced “One Hundred Thousand Golden Prescriptions,” documenting traditional remedies for acupuncture, infectious diseases, and other common ailments.

Shanghai, Hunan, Guangdong, and Fujian provinces also launched large-scale campaigns, compiling hundreds of thousands, and in some cases millions, of remedies. Even industry and transportation sectors, such as the railways and pharmaceutical companies, joined the effort, collecting and verifying prescriptions with impressive dedication.

The results of this mass movement were profound. First, it significantly improved public health. Countless remedies addressed a wide range of conditions, from parasitic infections and snakebites to injuries, fractures, epilepsy, and influenza. In 1956, a team treating schistosomiasis in Wuhan successfully alleviated abdominal swelling in thousands of patients using locally collected formulas.

In Nantong, Jiangsu, a physician’s specialized anti-snakebite remedy became widely applied, while in Hebei, acupuncture and herbal remedies helped curb influenza outbreaks. In Fujian, practitioners successfully treated over a hundred severe burn cases using traditional formulas. These practical applications demonstrated the tangible health benefits of integrating folk knowledge into public health.

Second, the campaign played a critical role in preserving and modernizing China’s medical heritage. While traditional medicine had a rich history of empirical success, it lacked systematic scientific frameworks. By collecting and studying these remedies, researchers could analyze and document their efficacy, refine formulations, and eventually integrate them into modern medical practice.

This process not only strengthened the scientific understanding of Chinese medicine but also ensured that its valuable knowledge was transmitted to future generations. The National Institute of Chinese Medicine, for example, selected hundreds of remedies for compilation, testing, and clinical application, laying the groundwork for what would eventually become a modernized and scientifically informed Chinese medical system.

Finally, the movement fostered a sense of national pride and loyalty. Physicians and ordinary citizens alike contributed remedies out of gratitude and civic duty, motivated by a desire to serve both their communities and the nation.

Many practitioners gained recognition and were elected to governmental and advisory positions, further integrating traditional medicine into the fabric of the state. Stories of individuals offering multi-generational family formulas illustrate how personal dedication intertwined with national purpose, reflecting the broader societal mobilization characteristic of early PRC initiatives.

The collection of folk remedies in the early years of the People’s Republic was far more than a medical exercise. It was a carefully orchestrated national campaign that combined political guidance, grassroots participation, and scientific inquiry.

It strengthened public health, preserved a rich medical tradition, advanced the modernization of Chinese medicine, and cultivated a sense of civic responsibility and patriotic commitment among practitioners and the public alike. This remarkable chapter in China’s history demonstrates the power of cultural heritage, political organization, and mass mobilization coming together to serve the people and the nation.

Source: zzxk, baidu, zhihu, yizhe dum, njucm

Digital and Green Economies Propel a New Era of China-ASEAN Cooperation, Benefiting Over 2 Billion People

POLITIK

Tendenzblick

-

January 15, 2026

0

Digital and Green Economies Propel a New Era of China-ASEAN Cooperation, Benefiting Over 2 Billion People

In 2026, the China-ASEAN Free Trade Area (CAFTA) marks its 16th anniversary, reflecting a period of sustained growth and deepening integration. Over the years, CAFTA has benefited more than two billion people, with China remaining ASEAN’s largest trading partner for 16 consecutive years, while ASEAN has been China’s top trade partner for five straight years. The partnership has evolved beyond traditional goods trade, moving toward a deeper embedding in industrial and value chains, creating what officials describe as a “community of shared destiny.”

The signing of the CAFTA 3.0 Upgrade Protocol on October 28, 2025, represents a strategic leap in this long-standing cooperation. Building on the foundations laid by CAFTA 1.0 and 2.0, the 3.0 version emphasizes trade facilitation, integration of emerging sectors, and regulatory alignment to enhance the efficiency and predictability of cross-border commerce. It reflects China and ASEAN’s shared vision of adapting to evolving global and regional economic trends, while also preparing for future challenges in trade and investment.

The impact of these agreements can be seen in practical terms at the Guangxi Youyiguan border crossing between China and Vietnam. The port has been upgraded into a smart logistics hub, integrating artificial intelligence, biometric verification, and data-sharing platforms. Automated container trucks, or “driverless trucks,” now transport goods efficiently, with customs clearance processes streamlined by digital systems that allow goods to pass in seconds.

China’s authorities report that these upgrades have increased operational efficiency by approximately 75%, with customs officers merely needing to submit orders through the smart port system, while the platform handles the rest. This modernization reflects the accelerated implementation of the CAFTA 3.0 protocol and its focus on trade facilitation.

The 3.0 protocol introduces several forward-looking measures. Digital economy and green economy sectors are included for the first time, allowing businesses in these emerging areas to benefit from harmonized technical standards and mutual recognition of certifications.

Companies previously constrained by divergent regulations, such as a Zhejiang-based renewable energy firm exporting storage batteries to ASEAN countries, can now navigate cross-border trade more smoothly. By aligning standards, CAFTA 3.0 reduces compliance costs and expands market opportunities for enterprises operating in these new growth sectors.

Support for small and medium-sized enterprises (SMEs) is another key feature of CAFTA 3.0. Measures include enhanced information-sharing, guidance on sustainable business practices, and policies to ensure SMEs can access digital trade platforms and simplified customs procedures.

Practical examples demonstrate the protocol’s benefits: a Qingdao-based importer of black and green beans from Myanmar was able to access zero tariffs despite minor discrepancies in documentation, thanks to flexible application of customs rules under the new framework. These steps aim to integrate SMEs more fully into regional value chains and provide equitable opportunities to participate in global trade.

Since the launch of the CAFTA framework in 2002, China and ASEAN have consistently expanded trade and investment agreements, culminating in the full establishment of the free trade area in 2010. Trade volume has grown exponentially, reaching 6.82 trillion RMB and covering over two billion people. The successive upgrades—from CAFTA 1.0’s market access focus, through 2.0’s expanded openness, to 3.0’s forward-looking regulatory and sectoral enhancements—reflect an ongoing effort to keep pace with global economic shifts and deepen bilateral integration.

Experts highlight that CAFTA 3.0 represents not just quantitative growth but qualitative transformation. By addressing the diverse economic development levels among ASEAN countries, the protocol facilitates smoother trade for traditional sectors while creating new cooperation spaces in digital services, renewable energy, and smart city initiatives. China’s advanced manufacturing and technological expertise synergize with ASEAN’s intermediate goods processing, urban development, and regional market demands, forming an integrated, multi-layered collaboration model.

Future-oriented measures under CAFTA 3.0 aim to stimulate regional economic dynamics through innovative modes of cooperation. Standard-setting and co-development in digital economy sectors, cross-border industrial parks with integrated production and logistics functions, and regional digital trade platforms that allow SMEs to benefit alongside larger enterprises, are all designed to create a more inclusive, resilient, and sustainable economic ecosystem. Analysts suggest that these initiatives not only strengthen China-ASEAN relations but also provide replicable models for global trade governance, particularly for developing countries seeking deeper integration into global value chains.

The transformative impact of CAFTA 3.0 is evident. By incorporating digital and green economies, fostering SME development, and enhancing supply chain connectivity, it moves beyond a simple tariff reduction framework toward a rules-based, institutionally robust trade and investment ecosystem. At a time of global uncertainty, rising protectionism, and regional competition, the upgraded agreement offers both businesses and consumers improved efficiency, transparency, and access to diversified markets.

The evolution from CAFTA 1.0 to 3.0 reflects a trajectory of continuous improvement, strategic foresight, and adaptive governance. With trade between China and ASEAN reaching $982.3 billion in 2024—a 17-fold increase since 2002—the upgraded protocol is poised to elevate bilateral economic cooperation to new levels, underpinning broader regional development strategies and contributing to the long-term vision of a shared, prosperous future for Asia.

Source: gxzf gov cn, CCTV 13, thoidai, xinhua, cgtn